Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase 1a study of the CDK4/6 inhibitor, FCN-437c, in Chinese patients with HR + /HER2- advanced breast cancer.AuthorsZhang, Jian; Wang, Xiaojia; Wang, Xian; Hui, Aimin; Wu, Zhuli; Tian, Ling; Xu, Changjiang; Yang, Yuchen; Zhang, Wenjing; Hu, XichunPublicationInvestigational New Drugs, 2021, Vol 39, Issue 6, p1549ISSN0167-6997Publication typeArticleDOI10.1007/s10637-021-01133-2